SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)
NEOT 1.919+4.3%Jan 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john jansen who wrote (676)6/4/1999 1:51:00 PM
From: Marty  Read Replies (1) of 705
 
It's a little early, John, to make some of those judgements.

I still don't know any of the details on the new shares offering yet. What if, for example, the new shares are offered at say, 14 or 15? Probably getting money this way to complete the testing is cheaper and LESS dilutive than getting money by way of loans secured by stock at a discount?

I think they know that they have a breakthrough drug already and that they are playing it so they maximize the return to NEOT. Otherwise, they would have sold out to a pharma long ago to finance the risks in the testing process in return for a split in the proceeds. If there is no risk, if you know you have have a big winner, why share the proceeds?

It has nothing to do with egos. All they need a pharma for is for marketing and that comes much later.

Lets wait and see what the deal is and whether or not this financing is good or not for the stockholders in the long term. I saw that none of the current shareholders are selling any stock.

The efficacy of the drug remains the primary consideration. If they have what we think they have, very little else matters that much, and the question still is what is the best way to get it to market as soon as possible.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News